<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SOD2 downregulation &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/sod2-downregulation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 00:15:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>SOD2 downregulation &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Sod2 Downregulation Boosts Flat Lesions in Pancreatic Cancer</title>
		<link>https://bioengineer.org/sod2-downregulation-boosts-flat-lesions-in-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 00:14:47 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Flat lesions dysplasia]]></category>
		<category><![CDATA[Kanser öncülü lezyonlar]]></category>
		<category><![CDATA[oksidatif stres]]></category>
		<category><![CDATA[Oxidative stress cancer]]></category>
		<category><![CDATA[Pancreatic ductal adenocarcinoma]]></category>
		<category><![CDATA[Pankreatik kanser biyolojisi]]></category>
		<category><![CDATA[PDAC therapeutic targets]]></category>
		<category><![CDATA[SOD2 downregulation]]></category>
		<category><![CDATA[Terapötik Hedefler]]></category>
		<guid isPermaLink="false">https://bioengineer.org/sod2-downregulation-boosts-flat-lesions-in-pancreatic-cancer/</guid>

					<description><![CDATA[Recent groundbreaking research has shed light on the critical role of the enzyme Superoxide Dismutase 2 (SOD2) in pancreatic ductal adenocarcinoma (PDAC), a notoriously lethal form of cancer. This study, conducted by a team of scientists led by Fleming Martinez, H.R. Döppler, and R. Argo, highlights the intricate relationship between SOD2 levels and the progression [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320071</post-id>	</item>
	</channel>
</rss>
